Skip to Main Content

Amir Toor, M.D.

Professor

School
Medical School
Department
Internal Medicine

You have reached the Academic Profile.

For more information on the doctor and patient care, please visit the clinical profile.

  • Publications

    Star Featured Publications

    Feasibility of intravenous vitamin C supplementation in allogeneic hematopoietic cell transplant recipients.
    Simmons GL, Sabo R, Qayyum R, Aziz M, Martin E, Bernard RJ, Sriparna M, McIntire C, Krieger E, Brophy DF, Natarajan R, Iii AF, Roberts CH, Toor A, EJHaem 2024 Oct 5 5 1043-1047
    SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study.
    Hill JA, Martens MJ, Young JH, Bhavsar K, Kou J, Chen M, Lee LW, Baluch A, Dhodapkar MV, Nakamura R, Peyton K, Howard DS, Ibrahim U, Shahid Z, Armistead P, Westervelt P, McCarty J, McGuirk J, Hamadani M, DeWolf S, Hosszu K, Sharon E, Spahn A, Toor AA, Waldvogel S, Greenberger LM, Auletta JJ, Horowitz MM, Riches ML, Perales MA, Clin Infect Dis 2024 Aug 79 2 542-554
    Increased donor inhibitory KIR are associated with reduced GVHD and improved survival following HLA-matched unrelated donor HCT in paediatric acute leukaemia.
    Krieger E, Qayyum R, Toor A, Br J Haematol 2024 May 204 5 1935-1943
    Defining and Grading Infections in Clinical Trials Involving Hematopoietic Cell Transplantation: A Report From the BMT CTN Infectious Disease Technical Committee.
    Shahid Z, Etra AM, Levine JE, Riches ML, Baluch A, Hill JA, Nakamura R, Toor AA, Ustun C, Young JH, Perales MA, Epstein DJ, Murthy HS, Transplant Cell Ther 2024 May 30 5 540.e1-540.e13